Table 3.
MetS/Components | Dietary Inflammatory Index OR (95% CI) | CRP (Continuous) OR (95% CI) |
|||
---|---|---|---|---|---|
Tertile 1 | Tertile 2 | Tertile 3 | Continuous | ||
Metabolic Syndrome | |||||
Model 1 b | 1.00(Ref.) | 0.74(0.58–0.95) | 0.72(0.56–0.92) | 0.85(0.78–0.92) | 3.83(3.05–4.80) |
Model 2 c | 1.00(Ref.) | 0.76(0.56–1.03) | 1.02(0.75–1.40) | 0.93(0.83–1.04) | 1.66(1.26–2.18) * |
Waist circumference | |||||
Model 1 b | 1.00(Ref.) | 0.86(0.68–1.09) | 0.69(0.54–0.86) | 0.85(0.79–0.93) | 4.61(3.67–5.79) |
Model 2 c | 1.00(Ref.) | 0.92(0.64–1.32) | 0.86(0.59–1.24) | 0.93(0.81–1.06) | 1.91(1.36–2.66) * |
Blood pressure | |||||
Model 1 b | 1.00(Ref.) | 0.96(0.76–1.21) | 0.86(0.68–1.08) | 0.91(0.84–0.99) | 2.80(2.28–3.45) |
Model 2 c | 1.00(Ref.) | 1.04(0.77–1.39) | 1.40(1.03–1.89) * | 1.06(0.96–1.18) | 1.17(0.89–1.53) |
HDL-cholesterol | |||||
Model 1 b | 1.00(Ref.) | 0.90(0.69–1.17) | 1.01(0.78–1.31) | 0.96(0.88–1.06) | 2.13(1.72–2.64) |
Model 2 c | 1.00(Ref.) | 0.95(0.71–1.26) | 1.17(0.88–1.56) | 1.02(0.92–1.12) | 1.64(1.27–2.11) * |
Triglycerides | |||||
Model 1 b | 1.00(Ref.) | 0.69(0.54–0.88) | 0.73(0.58–0.93) | 0.88(0.81–0.96) | 3.01(2.43–3.72) |
Model 2 c | 1.00(Ref.) | 0.73(0.55–0.96) | 1.03(0.78–1.37) | 0.99(0.90–1.09) | 1.44(1.12–1.85) * |
Fasting glucose | |||||
Model 1 b | 1.00(Ref.) | 0.78(0.61–1.00) | 0.71(0.56–0.92) | 0.86(0.79–0.94) | 2.47(2.00–3.05) |
Model 2 c | 1.00(Ref.) | 0.78(0.59–1.04) | 0.85(0.64–1.14) | 0.91(0.82–1.00) | 1.73(1.34–2.24) * |
MetS: metabolic syndrome, DII: dietary inflammatory index, CRP: C-reactive protein, HDL-cholesterol: high-density lipoprotein cholesterol. a MetS outcomes and its components were analyzed as dichotomous variables with binary logistic regression; b Model 1 was used to obtain the crude odds ratio; c Model 2 was adjusted for age, gender, city, education level, family monthly expenditure on food, smoking status and BMI. * OR (95% CI) of adjusted model that were significant.